News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cassella James V
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/13/2018 |
4/A
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 4,418 shares
@ $22.9, valued at
$101.2k
|
|
| 04/02/2013 |
4/A
| Cassella James V (EVP, R&D and CSO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 43,750 shares
@ $4.42, valued at
$193.4k
Granted 87,500 options to buy
@ $4.42, valued at
$386.8k
|
|
| 12/21/2009 |
4/A
| Cassella James V (SVP, Research & Development) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Sold 7,731 shares
@ $2.4071, valued at
$18.6k
Sold 4,283 shares
@ $2.2007, valued at
$9.4k
Sold 12,405 shares
@ $2.1269, valued at
$26.4k
|
|
|
|